Opinion
Video
Author(s):
Panelists discuss how their clinical experiences with topical ruxolitinib are shaping new treatment paradigms for vitiligo, while also addressing challenges related to medication access.
Topical TCA and Methoxsalen Not Clinically Effective for Acral Vitiligo
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Beyond Topicals: Surgical Solutions for Vitiligo
ReV Up Your Vitiligo Treatment Strategies
Noninvasive Imaging Is Transforming Vitiligo Monitoring With OCT Technology
Further Research Can Confirm Machine Learning’s Accuracy in Detecting Vitiligo